• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[躯体形式障碍和功能性躯体综合征患者的心理药物治疗]

[Psychopharmacological treatment in patients with somatoform disorders and functional body syndromes].

作者信息

Kapfhammer H P

机构信息

Klinik für Psychiatrie, Medizinische Universität Graz, Auenbruggerplatz 31, 8036 Graz, Österreich.

出版信息

Nervenarzt. 2012 Sep;83(9):1128-41. doi: 10.1007/s00115-011-3446-9.

DOI:10.1007/s00115-011-3446-9
PMID:22895795
Abstract

Somatoform disorders and functional body syndromes define a major, diagnostically heterogeneous group of patients with medically unexplained physical symptoms. Psychopharmacological approaches can be derived from the conceptualization of somatoform symptoms and syndromes within a biopsychosocial model. The survey presented focuses on randomized, double-blind and placebo-controlled studies. Antidepressants show a statistically and clinically relevant impact on many somatoform symptoms. In special reference to pain symptoms serotonergic and noradrenergic antidepressants seem to mediate a more favorable effect than selective serotonin reuptake inhibitors. For some functional body syndromes, e.g. irritable bowel syndrome and fibromyalgia, a major analgesic effect of antidepressants can be underlined as well. The empirical data for fibromyalgia, however, seem to be more convincing than for irritable bowel syndrome. Pregabalin holds an empirically well established position in the treatment of fibromyalgia. As yet there is no convincing psychopharmacological strategy for chronic fatigue syndrome. Probably due to the inherent relationships to anxiety, obsessive-compulsive and depressive disorders, both hypochondria and body dysmorphic disorder can be positively treated by serotonergic antidepressants as well.

摘要

躯体形式障碍和功能性躯体综合征定义了一组主要的、诊断上异质性的患者,他们有医学上无法解释的躯体症状。心理药理学方法可以从生物心理社会模型中躯体形式症状和综合征的概念化推导出来。所呈现的调查聚焦于随机、双盲和安慰剂对照研究。抗抑郁药对许多躯体形式症状显示出统计学和临床上相关的影响。特别针对疼痛症状,血清素能和去甲肾上腺素能抗抑郁药似乎比选择性5-羟色胺再摄取抑制剂介导更有利的效果。对于一些功能性躯体综合征,如肠易激综合征和纤维肌痛,抗抑郁药的主要镇痛作用也可以得到强调。然而,纤维肌痛的经验数据似乎比肠易激综合征更有说服力。普瑞巴林在纤维肌痛治疗中占据着经验上确立良好的地位。对于慢性疲劳综合征,目前尚无令人信服的心理药理学策略。可能由于与焦虑症、强迫症和抑郁症的内在关系,疑病症和躯体变形障碍也都可以用血清素能抗抑郁药进行有效治疗。

相似文献

1
[Psychopharmacological treatment in patients with somatoform disorders and functional body syndromes].[躯体形式障碍和功能性躯体综合征患者的心理药物治疗]
Nervenarzt. 2012 Sep;83(9):1128-41. doi: 10.1007/s00115-011-3446-9.
2
Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment.功能性胃肠疾病与精神障碍的关系:对治疗的启示
World J Gastroenterol. 2007 Apr 14;13(14):2020-7. doi: 10.3748/wjg.v13.i14.2020.
3
[Possibilities and limitations of psychopharmacological treatments in patients with psychological comorbidity].[心理共病患者心理药物治疗的可能性与局限性]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Jan;54(1):37-45. doi: 10.1007/s00103-010-1178-9.
4
Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis.抗抑郁药对心因性疼痛和躯体形式疼痛障碍是否具有镇痛作用?一项荟萃分析。
Psychosom Med. 1998 Jul-Aug;60(4):503-9. doi: 10.1097/00006842-199807000-00019.
5
Psychopharmacological treatment of dermatological patients--when simply talking does not help.皮肤病患者的心理药物治疗——当单纯谈话不起作用时。
J Dtsch Dermatol Ges. 2007 Dec;5(12):1101-6. doi: 10.1111/j.1610-0387.2007.06398.x. Epub 2007 Sep 17.
6
Antidepressants and cognitive-behavioral therapy for symptom syndromes.用于症状综合征的抗抑郁药和认知行为疗法。
CNS Spectr. 2006 Mar;11(3):212-22. doi: 10.1017/s1092852900014383.
7
Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes.抗抑郁药与躯体症状:治疗作用正从情感谱系障碍扩展至功能性躯体综合征。
J Clin Psychiatry. 2003 Jul;64(7):745-6.
8
Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review.医学上无法解释的身体症状、焦虑和抑郁:一项元分析综述。
Psychosom Med. 2003 Jul-Aug;65(4):528-33. doi: 10.1097/01.psy.0000075977.90337.e7.
9
The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome.抑郁症在与慢性疲劳综合征相关的疼痛、心理生理综合征及医学上无法解释的症状中的作用。
J Affect Disord. 1999 Oct;55(2-3):143-8. doi: 10.1016/s0165-0327(98)00218-3.
10
Psychopharmacotherapy of somatic symptoms disorders.躯体症状障碍的精神药理学治疗。
Int Rev Psychiatry. 2013 Feb;25(1):107-15. doi: 10.3109/09540261.2012.729758.

引用本文的文献

1
[Conversion disorders].[转换障碍]
Nervenarzt. 2013 Mar;84(3):395-406. doi: 10.1007/s00115-013-3740-9.
2
Pregabalin abuse and dependence in Germany: results from a database query.派格宾滥用和依赖在德国:数据库查询的结果。
Eur J Clin Pharmacol. 2013 Jun;69(6):1335-42. doi: 10.1007/s00228-012-1464-6. Epub 2013 Jan 5.
3
Non-specific, functional, and somatoform bodily complaints.非特异性、功能性和躯体形式躯体抱怨。

本文引用的文献

1
Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.哌醋甲酯对疲劳和抑郁的影响:一项随机、双盲、安慰剂对照试验。
J Pain Symptom Manage. 2012 Jan;43(1):68-77. doi: 10.1016/j.jpainsymman.2011.03.026.
2
An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.一项国际、随机、双盲、安慰剂对照的 III 期试验,评估普瑞巴林单药治疗纤维肌痛患者的疗效。
J Rheumatol. 2011 Dec;38(12):2643-52. doi: 10.3899/jrheum.110569. Epub 2011 Oct 1.
3
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
Dtsch Arztebl Int. 2012 Nov;109(47):803-13. doi: 10.3238/arztebl.2012.0803. Epub 2012 Nov 23.
度洛西汀治疗纤维肌痛患者疲劳的多个维度改善:一项随机、安慰剂对照试验的二次分析。
Arthritis Res Ther. 2011 Jun 13;13(3):R86. doi: 10.1186/ar3359.
4
Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.米拉昔布治疗纤维肌痛的长期治疗反应。3 个月研究后进行的为期 1 年的欧洲扩展研究。
J Rheumatol. 2011 Jul;38(7):1403-12. doi: 10.3899/jrheum.101025. Epub 2011 Apr 1.
5
Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.氨磺必利与氟西汀治疗慢性疲劳综合征的对照研究:一项初步研究。
Eur Neuropsychopharmacol. 2011 Mar;21(3):282-6. doi: 10.1016/j.euroneuro.2010.10.008. Epub 2010 Nov 26.
6
Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.在纤维肌痛症的普瑞巴林临床试验中,疼痛与抑郁和焦虑症状之间的关系。
Psychosomatics. 2010 Nov-Dec;51(6):489-97. doi: 10.1176/appi.psy.51.6.489.
7
Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.灵活剂量度洛西汀治疗纤维肌痛:一项随机、双盲、安慰剂对照试验。
J Rheumatol. 2010 Dec;37(12):2578-86. doi: 10.3899/jrheum.100365. Epub 2010 Sep 15.
8
Emerging pharmacologic therapies for irritable bowel syndrome.肠易激综合征的新兴药物疗法
Curr Gastroenterol Rep. 2010 Oct;12(5):408-16. doi: 10.1007/s11894-010-0124-1.
9
A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.米那普仑单药治疗纤维肌痛的两项随机、双盲、安慰剂对照临床试验的汇总分析。
Pain Pract. 2011 Mar-Apr;11(2):120-31. doi: 10.1111/j.1533-2500.2010.00403.x.
10
Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.米那普明每日100毫克治疗纤维肌痛患者的疗效与安全性:一项随机、双盲、安慰剂对照试验的结果
Arthritis Rheum. 2010 Sep;62(9):2745-56. doi: 10.1002/art.27559.